Our study showed that SEC61G was upregulated in LUAD tissues compared with adjacent normal tissues in the TCGA-LUAD cohort, which was consistent with previous studies founded in glioblastoma and hepatocellular carcinoma [14, 17]. Here, SEC61G is linked to hepatocellular carcinoma.